|Articles|May 24, 2019

A Wine Tasting With a Side of Tularemia

A deep dive into an outbreak of tularemia linked to contaminated must and wine that led to several complicated infections, requiring extended durations of treatment.

Tularemia is a zoonotic disease that continues to teach us a lot about the transmission of pathogens between humans and animals. The often-rare disease is brought on by the bacteria Francisella tularensis, which consists of 2 subspecies, Holarctica, which is frequently seen in the Northern hemisphere, and tularensis, which is mostly commonly detected in North America. Unfortunately, due to its rarity and non-specific symptoms, tularemia is commonly mistaken for other diseases.

Outbreaks of the disease tend to be smaller events, clustered around wild-life exposures or inhalation of contaminated dust/aerosols. However, since tularemia outbreaks tend to be an infrequent occurrence, when one does happen, there is always intrigue.

A recent article in the International Journal of Infectious Diseases sheds light on a cluster of cases associated with a grape harvest. Although this might sound like a trip to Napa Valley gone wrong, this German outbreak provides details on the variety of mechanisms of transmission that tularemia exhibits, including tick/deer fly bites, handling infected animals, laboratory exposures, inhalation of contaminated dust, or even contaminated food and water.

The initial case in the German outbreak occurred in a 46-year-old patient who attended a wine tasting and subsequently experienced a severe fever and swollen lymph nodes, which spiraled into severe tonsillopharyngitis. Submandibular lymph node swelling increased and, after a consultation with an ear, nose, and throat physician, an antibody test for F tularensis was ordered and returned positive. Despite 500 mg of ciprofloxacin twice a day for 2 weeks, lymph node swelling worsened and hospitalization was required.

In addition to the initial case, there were 5 other patients infected following consumption of must (grape juice) or wine from the same vineyard. Three male and 2 females, ranging in age from 3 to 41 years, experienced symptoms beginning 4 to 24 days after exposure. Nearly all of the ill experienced cervical lymphadenopathy and pharyngitis, as well as fever and general malaise. Serological confirmation of tularemia led to appropriate treatment and symptoms resolved within 23 to 45 days.

The epidemiological investigation pinpoints the likely source of transmission as must from a vineyard in the area of Rhineland-Palatinate, Germany. In the must-making process, grapes are collected by an automatic harvest machine and then pressed to produce juice without filtering out extraneous materials. The investigators note that “consumption of fresh must with the highest genomic equivalents of F tularensis ssp. Holarctica was significantly associated with the development of disease.”

In the past, outbreaks of tularemia have been linked to contaminated food and water and, in this case, it is highly likely that when the grapes were collected by the automatic harvest machine, they were contaminated by an infected rodent or rabbit.

This tularemia outbreak is not the first linked with consumption of grapes in a German vineyard. In October 2016, 6 grape harvesters acquired tularemia after exposure to grape must that was later found to be contaminated with wood mice DNA.

The investigators on the latest report heavily emphasized that not only is tularemia very infectious, but also that the treatment process can be complicated. The recommended duration of treatment is often 14 days, but complications and continuation of symptoms seen in this outbreak led the authors to advise upwards of 21 days of treatment.

Overall, this outbreak sheds light on yet another route of transmission for this zoonotic disease, but also provides an example of how to manage an outbreak when recommended treatment may not be sufficient to resolve symptoms.


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.